Compare NMG & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NMG | LFCR |
|---|---|---|
| Founded | 2011 | 1986 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.7M | 241.8M |
| IPO Year | 2015 | 1996 |
| Metric | NMG | LFCR |
|---|---|---|
| Price | $0.94 | $6.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | $3.68 | ★ $6.28 |
| AVG Volume (30 Days) | 438.5K | ★ 538.0K |
| Earning Date | 11-11-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $0.87 | $3.63 |
| 52 Week High | $3.59 | $8.98 |
| Indicator | NMG | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 35.55 | 65.20 |
| Support Level | $0.87 | $4.20 |
| Resistance Level | $2.42 | $6.48 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | 0.02 | -0.07 |
| Stochastic Oscillator | 40.00 | 36.59 |
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The Company currently operates in two segments: the Mining projects (which includes the Matawinie Mine project and the Uatnan Mining Project) and the Battery Material Plant project.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.